Nora Hansen, MD
Surgical Oncology · Chicago, ILNPI 1912970930
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,270 of the $41,054 with a category attached, or 71.3%. Merck accounts for 89.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $20,313 and has fallen 98.9% since, to $219 in 2025. Among surgical oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $662.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$37K
- AstraZeneca$2K
- Davol Inc.$630
- Beigene USA, Inc.$350
- Mirati Therapeutics, Inc.$243
- ADC Therapeutics America, Inc.$229
- plus $1K from 13 others
What the payments were for
- Consulting fees$3,7469%
- Speaking & faculty fees$29,27071%
- Travel & lodging$5,12012%
- Food & beverage$2,9187%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 33 | $36,600 |
| AstraZeneca | 2 | $1,645 |
| Davol Inc. | 2 | $630 |
| Beigene USA, Inc. | 3 | $350 |
| Mirati Therapeutics, Inc. | 2 | $243 |
| ADC Therapeutics America, Inc. | 2 | $229 |
| Exelixis Inc. | 2 | $180 |
| Bristol Myers Squibb | 4 | $178 |
| Beone Medicines USA, Inc. | 1 | $150 |
| Octapharma USA, Inc. | 2 | $146 |
| AbbVie | 1 | $133 |
| AVEO Pharmaceuticals, Inc. | 1 | $126 |
| Incyte Corporation | 1 | $105 |
| Genmab U.S., Inc. | 1 | $104 |
| Immunogen, Inc. | 1 | $87 |
| Gilead | 1 | $69 |
| Focal Therapeutics, Inc. | 1 | $41 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,054 in reported general payments places this provider in the 95th percentile of 55 surgical oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Chicago
- Fadi DahdalehChicago$198K
- Jeffrey WayneChicago$38K
- David BentremChicago$34K
- Mecker MollerChicago$25K
- Shishir MaithelChicago$16K
- Aslam EjazChicago$16K
- Ryan MerkowChicago$16K
- Xavier KeutgenChicago$13K
- Alejandra Perez TamayoChicago$6K
- Juliet LumatiChicago$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.